| 2021-07-12 | +21.8% | legal | SEC EDGAR | IRMD 8-K: 5.02 and (SEC Filing) |
| 2025-08-01 | +21.3% | earnings | Seeking Alpha | Iradimed outlines $100M revenue run-rate for 2026 driven by new 3870 pump launch |
| 2025-08-01 | +21.3% | earnings | Seeking Alpha | IRADIMED CORPORATION (IRMD) Q2 2025 Earnings Call Transcript |
| 2025-08-01 | +21.3% | earnings | Seeking Alpha | iRadimed Non-GAAP EPS of $0.49 beats by $0.06, revenue of $20.4M beats by $0.39M |
| 2025-08-01 | +21.3% | legal | SEC EDGAR | IRMD 8-K: 2.02 and (SEC Filing) |
| 2022-02-04 | +19.7% | legal | SEC EDGAR | IRMD 8-K: 2.02 and (SEC Filing) |
| 2022-04-29 | -14.1% | legal | SEC EDGAR | IRMD 8-K: 2.02 and (SEC Filing) |
| 2022-04-29 | -14.1% | legal | SEC EDGAR | IRMD 8-K: 5.02 and (SEC Filing) |
| 2025-11-03 | +13.9% | earnings | Seeking Alpha | IRADIMED targets $100M revenue milestone with new 3870 MRI IV pump rollout through 2026 |
| 2025-11-03 | +13.9% | earnings | Seeking Alpha | IRADIMED CORPORATION (IRMD) Q3 2025 Earnings Call Transcript |
| 2025-11-03 | +13.9% | earnings | Seeking Alpha | iRadimed beats top-line and bottom-line estimates; initiates Q4 and raises FY25 outlook |
| 2025-11-03 | +13.9% | legal | SEC EDGAR | IRMD 8-K: 2.02 and (SEC Filing) |
| 2025-05-29 | +11.8% | legal | Seeking Alpha | Iradimed rises after FDA nod for infusion pump system |
| 2025-05-29 | +11.8% | legal | SEC EDGAR | IRMD 8-K: 8.01 and (SEC Filing) |
| 2023-08-03 | +11.5% | legal | SEC EDGAR | IRMD 8-K: 2.02 and (SEC Filing) |
| 2023-02-07 | -10.2% | legal | SEC EDGAR | IRMD 8-K: 8.01 (SEC Filing) |
| 2023-02-02 | +9.8% | legal | SEC EDGAR | IRMD 8-K: 2.02 and (SEC Filing) |
| 2025-02-13 | -9.7% | earnings | Seeking Alpha | IRadimed projects $78M-$82M revenue for FY2025 amid strong pump demand and FDA clearance timelines |
| 2025-02-13 | -9.7% | earnings | Seeking Alpha | IRADIMED CORPORATION (IRMD) Q4 2024 Earnings Call Transcript |
| 2025-02-13 | -9.7% | news | Seeking Alpha | iRadimed raises dividend by 13.3% to $0.17 |
| 2025-02-13 | -9.7% | earnings | Seeking Alpha | iRadimed beats top-line estimates; initiates Q1 and FY25 outlook |
| 2025-02-13 | -9.7% | legal | SEC EDGAR | IRMD 8-K: 2.02 and (SEC Filing) |
| 2026-02-09 | +9.3% | earnings | Seeking Alpha | iRadimed Q4 2025 Earnings Preview |
| 2023-11-06 | -9.3% | legal | SEC EDGAR | IRMD 8-K: 5.02 and (SEC Filing) |
| 2022-02-07 | +7.9% | legal | SEC EDGAR | IRMD 8-K: 8.01 and (SEC Filing) |
| 2026-02-10 | +7.7% | earnings | Seeking Alpha | IRadimed targets $100M-plus revenue run rate in 2026 as 3870 pump ramps |
| 2026-02-10 | +7.7% | earnings | Seeking Alpha | IRADIMED CORPORATION (IRMD) Q4 2025 Earnings Call Transcript |
| 2026-02-10 | +7.7% | earnings | Seeking Alpha | iRadimed beats top-line and bottom-line estimates; initiates Q1 and FY26 outlook |
| 2026-02-10 | +7.7% | news | Seeking Alpha | iRadimed raises dividend by 17.6% to $0.20 |
| 2026-02-10 | +7.7% | legal | SEC EDGAR | IRMD 8-K: 2.02 and (SEC Filing) |
| 2026-02-10 | +7.7% | news | The Motley Fool | Why Iradimed Stock Soared Today - The Motley Fool |
| 2024-02-08 | -7.5% | legal | SEC EDGAR | IRMD 8-K: 2.02 and (SEC Filing) |
| 2023-05-04 | +7.4% | legal | SEC EDGAR | IRMD 8-K: 2.02 and (SEC Filing) |
| 2024-10-31 | -7.2% | earnings | Seeking Alpha | IRADIMED CORPORATION (IRMD) Q3 2024 Earnings Call Transcript |
| 2024-10-31 | -7.2% | news | Seeking Alpha | iRadimed declares $0.15 dividend |
| 2024-10-31 | -7.2% | earnings | Seeking Alpha | iRadimed Non-GAAP EPS of $0.43 beats by $0.04, revenue of $18.33M beats by $0.23M |
| 2024-10-31 | -7.2% | legal | SEC EDGAR | IRMD 8-K: 2.02 and (SEC Filing) |
| 2021-04-30 | +6.4% | legal | SEC EDGAR | IRMD 8-K: 2.02 and (SEC Filing) |
| 2021-10-29 | +6.0% | legal | SEC EDGAR | IRMD 8-K: 2.02 and (SEC Filing) |
| 2022-11-03 | +4.8% | legal | SEC EDGAR | IRMD 8-K: 2.02 and (SEC Filing) |
| 2024-05-02 | +4.2% | legal | SEC EDGAR | IRMD 8-K: 2.02 and (SEC Filing) |
| 2025-08-04 | +4.1% | news | Seeking Alpha | iRadimed declares $0.17 dividend |
| 2023-01-19 | +4.0% | legal | SEC EDGAR | IRMD 8-K: 2.02 and (SEC Filing) |
| 2025-04-08 | -3.9% | news | Seeking Alpha | IRadimed Corporation: Steady, Low-Risk Grower In The Devices Space |
| 2023-02-03 | -3.6% | legal | SEC EDGAR | IRMD 8-K: 1.01 and (SEC Filing) |
| 2026-04-06 | -3.4% | news | Cổng thông tin điện tử Tỉnh Sơn La | Is iRadimed Corporation (IRMD) Stock Stronger Than Peers | Price at $96.70, Up 0.49% - Dividend Growth - Cổng thông tin điện tử Tỉnh Sơn La |
| 2022-11-04 | -3.3% | legal | SEC EDGAR | IRMD 8-K: 1.01, 2.03 (SEC Filing) |
| 2021-11-23 | +3.2% | legal | SEC EDGAR | IRMD 8-K: 8.01 (SEC Filing) |
| 2025-05-05 | -3.2% | earnings | Seeking Alpha | IRADIMED outlines Q2 2025 revenue guidance of $19.7M-$19.9M amid strong pump shipments |
| 2025-05-05 | -3.2% | earnings | Seeking Alpha | IRADIMED CORPORATION (IRMD) Q1 2025 Earnings Call Transcript |
| 2025-05-05 | -3.2% | earnings | Seeking Alpha | iRadimed beats top-line and bottom-line estimates; initiates Q2 and reaffirms FY25 outlook |
| 2025-05-05 | -3.2% | legal | SEC EDGAR | IRMD 8-K: 2.02 and (SEC Filing) |
| 2026-04-10 | -3.0% | news | GlobeNewswire | IRADIMED CORPORATION to Participate at the 25th Annual Needham Virtual Healthcare Conference |
| 2026-04-10 | -3.0% | executive | Stock Titan | IRADIMED's finance chief lines up investor meetings at Needham event - Stock Titan |
| 2025-08-21 | +2.9% | news | Seeking Alpha | IRadimed: Continued Value Unlock With Extensive Reinvestment Runway |
| 2025-08-21 | +2.9% | news | Seeking Alpha | IRadimed: Continued Value Unlock With Extensive Reinvestment Runway (NASDAQ:IRMD) - Seeking Alpha |
| 2026-04-15 | -2.8% | legal | MT Newswires | Iradimed Insider Sold Shares Worth $697,189, According to a Recent SEC Filing |
| 2026-04-15 | -2.8% | executive | Stock Titan | Rule 10b5-1 sales by IRADIMED (IRMD) CEO-linked dynasty trust - Stock Titan |
| 2026-04-15 | -2.8% | earnings | MarketBeat | Insider Selling: iRadimed (NASDAQ:IRMD) CEO Sells 5,000 Shares of Stock - MarketBeat |
| 2026-04-15 | -2.8% | earnings | MarketBeat | Insider Selling: iRadimed (NASDAQ:IRMD) CEO Sells 2,500 Shares of Stock - MarketBeat |
| 2025-12-08 | +2.7% | news | Seeking Alpha | iRadimed declares $0.50 special dividend |
| 2025-12-08 | +2.7% | legal | SEC EDGAR | IRMD 8-K: 8.01 and (SEC Filing) |
| 2024-08-03 | +2.6% | earnings | Seeking Alpha | IRADIMED CORPORATION (IRMD) Q2 2024 Earnings Call Transcript |
| 2026-04-14 | -2.5% | earnings | Simply Wall St. | How The IRADIMED (IRMD) Story Is Shifting After Valuation Tweaks And 2026 Guidance |
| 2022-07-29 | -2.5% | legal | SEC EDGAR | IRMD 8-K: 2.02 and (SEC Filing) |
| 2022-07-29 | -2.5% | analyst | Zacks Investment Research | What is the current Price Target and Forecast for iRadimed (IRMD) - Zacks Investment Research |
| 2023-12-12 | +2.5% | legal | SEC EDGAR | IRMD 8-K: 8.01 and (SEC Filing) |
| 2023-11-03 | +2.4% | legal | SEC EDGAR | IRMD 8-K: 2.02 and (SEC Filing) |
| 2025-09-02 | -2.3% | legal | SEC EDGAR | IRMD 8-K: 5.02, 7.01 (SEC Filing) |
| 2026-04-13 | -2.0% | news | Cổng thông tin điện tử tỉnh Lào Cai | Is iRadimed Corporation (IRMD) Stock still in growth phase | Price at $92.30, Down 1.18% - Bollinger Bands - Cổng thông tin điện tử tỉnh Lào Cai |
| 2025-11-04 | +1.9% | news | Seeking Alpha | IRADIMED CORPORATION declares $0.17 dividend |
| 2026-03-16 | +1.8% | news | GlobeNewswire | IRADIMED CORPORATION to Participate at the 38th Annual Roth Conference |
| 2026-03-16 | +1.8% | news | Stock Titan | IRADIMED execs heading to Roth investor conference in California - Stock Titan |
| 2024-08-01 | -1.7% | news | Seeking Alpha | iRadimed declares $0.15 dividend |
| 2024-08-01 | -1.7% | legal | SEC EDGAR | IRMD 8-K: 2.02 and (SEC Filing) |
| 2021-07-30 | +1.7% | legal | SEC EDGAR | IRMD 8-K: 2.02 and (SEC Filing) |
| 2025-01-10 | -1.5% | earnings | Seeking Alpha | Iradimed reports preliminary fourth quarter revenues |
| 2025-01-10 | -1.5% | legal | SEC EDGAR | IRMD 8-K: 2.02 and (SEC Filing) |
| 2023-05-10 | -1.4% | legal | SEC EDGAR | IRMD 8-K: 8.01 and (SEC Filing) |
| 2026-03-18 | -1.2% | legal | MT Newswires | Iradimed Insider Sold Shares Worth $762,971, According to a Recent SEC Filing |
| 2022-10-11 | +1.2% | legal | SEC EDGAR | IRMD 8-K: 2.02, 8.01 (SEC Filing) |
| 2026-04-22 | -1.0% | legal | MT Newswires | Iradimed Insider Sold Shares Worth $694,124, According to a Recent SEC Filing |
| 2026-04-22 | -1.0% | executive | Stock Titan | IRADIMED (IRMD) CEO-linked trust sells 7,500 shares under plan - Stock Titan |
| 2026-04-22 | -1.0% | earnings | MarketBeat | Roger Susi Sells 5,000 Shares of iRadimed (NASDAQ:IRMD) Stock - MarketBeat |
| 2021-06-17 | +1.0% | legal | SEC EDGAR | IRMD 8-K: 8.01 (SEC Filing) |
| 2022-05-26 | -1.0% | legal | SEC EDGAR | IRMD 8-K: 5.02 and (SEC Filing) |
| 2026-03-25 | -1.0% | executive | Stock Titan | IRADIMED (NASDAQ: IRMD) CEO sells 7,500 trust-held shares under plan - Stock Titan |
| 2026-02-06 | -0.9% | earnings | simplywall.st | The total return for IRADIMED (NASDAQ:IRMD) investors has risen faster than earnings growth over the last five years - simplywall.st |
| 2026-04-01 | -0.9% | legal | MT Newswires | Iradimed Insider Sold Shares Worth $712,614, According to a Recent SEC Filing |
| 2026-04-01 | -0.9% | executive | Stock Titan | Insider trust tied to IRADIMED (IRMD) CEO sells 7,500 shares under 10b5-1 - Stock Titan |
| 2026-04-07 | -0.8% | legal | MT Newswires | Iradimed Insider Sold Shares Worth $717,208, According to a Recent SEC Filing |
| 2026-04-07 | -0.8% | executive | Investing.com | Iradimed CEO Susi sells $717k in IRMD stock - Investing.com |
| 2026-04-07 | -0.8% | executive | Stock Titan | IRADIMED (IRMD) CEO-linked trusts sell 7,500 company shares in plan trades - Stock Titan |
| 2026-04-07 | -0.8% | earnings | MarketBeat | Roger Susi Sells 2,500 Shares of iRadimed (NASDAQ:IRMD) Stock - MarketBeat |
| 2026-04-07 | -0.8% | news | Cổng thông tin điện tử Tỉnh Sơn La | Should I Sell iRadimed Corporation (IRMD) Stock Now | Price at $93.49, Down 2.27% - Reward Analysis - Cổng thông tin điện tử Tỉnh Sơn La |
| 2026-04-07 | -0.8% | news | Cổng thông tin điện tử tỉnh Lào Cai | Should I Sell iRadimed Corporation (IRMD) Stock Now | Price at $93.49, Down 2.27% - Hot Community Stocks - Cổng thông tin điện tử tỉnh Lào Cai |
| 2026-03-23 | +0.8% | news | Zacks | 3 Medical Instrument Stocks Tapping GenAI to Navigate Industry Woes |
| 2024-06-03 | +0.5% | legal | SEC EDGAR | IRMD 8-K: 1.01 and (SEC Filing) |
| 2024-03-23 | -0.4% | news | CNN | symbol__ Stock Quote Price and Forecast - CNN |
| 2022-10-06 | -0.3% | legal | SEC EDGAR | IRMD 8-K: 5.02 and (SEC Filing) |
| 2026-04-17 | +0.1% | analyst | DirectorsTalk Interviews | iRadimed Corporation (IRMD) Stock Analysis: Strong Buy Ratings and 29% Upside Potential - DirectorsTalk Interviews |
| 2025-11-27 | -0.1% | news | Yahoo Finance | Redditors Say IRadimed (IRMD) is Among The Best Small-Cap Stocks to Buy – Here’s Why - Yahoo Finance |
| 2026-04-26 | — | news | Insider Monkey | Here is Why Investors Should Pay Attention to IRADIMED Corp. (IRMD) |
| 2026-04-26 | — | news | Yahoo Finance | Here is Why Investors Should Pay Attention to IRADIMED Corp. (IRMD) - Yahoo Finance |
| 2026-04-26 | — | news | Insider Monkey | Here is Why Investors Should Pay Attention to IRADIMED Corp. (IRMD) - Insider Monkey |
| 2026-04-26 | — | analyst | HarianBasis.co | Iradimed Corp Stock Receives Strong Buy Ratings from Analysts - HarianBasis.co |
| 2026-04-24 | — | earnings | MarketBeat | iRadimed Corporation $IRMD Shares Sold by Copeland Capital Management LLC - MarketBeat |